title: Chylothorax after heart/lung transplantation.
abstract: Chylothorax is a potentially serious complication of lung and heart-lung transplantation. This article describes the clinical course of chylothorax in 3 heart-lung allograft recipients. We discuss management options, including dietary modifications, octreotide infusion, thoracic duct ligation and embolization, and surgical pleurodesis. In addition, we describe the novel use of aminocaproic acid to reduce lymph flow. We propose a multidisciplinary approach for the management of chylothorax that includes both medical and surgical options.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, California 94305, USA.
authors.forename: Tomasz M
authors.initials: TM
authors.lastname: Ziedalski
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Raffin
authors.forename: Daniel Y
authors.initials: DY
authors.lastname: Sze
authors.forename: John D
authors.initials: JD
authors.lastname: Mitchell
authors.forename: Robert C
authors.initials: RC
authors.lastname: Robbins
authors.forename: James
authors.initials: J
authors.lastname: Theodore
authors.forename: John L
authors.initials: JL
authors.lastname: Faul
mesh_terms: D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use; D002916:Chylothorax / Q000209:etiology* / Q000628:therapy; D003663:Decision Trees; D016041:Heart-Lung Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications
chemical_list: D000614:Aminocaproates